LEONID STOSMAN: Open Payments
NPI 1780383828 · LOVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,663 in 15 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $913 · 2025 $1,663
Food & beverage: $1,663
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $388 |
| Neurocrine BioSciences, Inc. | 3 | $298 |
| Otsuka America Pharmaceutical, Inc. | 3 | $249 |
| Alkermes, Inc. | 2 | $230 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $150 |
| ABBVIE INC. | 1 | $130 |
| Novo Nordisk Inc | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $92 |
Products named: CAPLYTA, INGREZZA, VRAYLAR, REXULTI, LYBALVI, Wegovy, ABILIFY MAINTENA, ARISTADA.
Industry payments across OH — which companies pay providers there.
